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MASP1 Mutations in Patients with Facial,
Umbilical, Coccygeal, and Auditory Findings
of Carnevale, Malpuech, OSA, and Michels Syndromes
Asli Sirmaci,1 Tom Walsh,2 Hatice Akay,3 Michail Spiliopoulos,1 Yıldırım Bayezit Sxakalar,4
Aylin Hasanefendioglu-Bayrak,5 Duygu Duman,6 Amjad Farooq,7 Mary-Claire King,2
and Mustafa Tekin1,*
Distinctive facial features consisting of hypertelorism, telecanthus, blepharophimosis, blepharoptosis, epicanthus inversus, periumbil-
ical defects, and skeletal anomalies are seen in autosomal-recessive Carnevale, Malpuech, Michels, and oculo-skeletal-abdominal (OSA)
syndromes. The gene or genes responsible for these syndromes were heretofore unknown. We report on three individuals from two
consanguineous Turkish families with findings characteristic of these syndromes, including facial dysmorphism, periumbilical depres-
sion, mixed hearing loss, radioulnar synostosis, and coccygeal appendage. Homozygosity mapping yielded an autozygous region on
chromosome 3q27 in both families. In one family, whole exome sequencing revealed a missense mutation, MASP1 c.2059G>A
(p.G687R), that cosegregated with the phenotype. In the second family, Sanger sequencing of MASP1 revealed a nonsense mutation,
MASP1 c.870G>A (p.W290X), that also cosegregated with the phenotype. Neither mutation was found in 192 Turkish controls or
1200 controls of various other ancestries. MASP1 encodes mannan-binding lectin serine protease 1. The two mutations occur in
a MASP1 isoform that has been reported to process IGFBP-5, thereby playing a critical role in insulin growth factor availability during
craniofacial and muscle development. These results implicate mutations of MASP1 as the cause of a human malformation syndrome
and demonstrate the involvement of MASP1 in facial, umbilical, and ear development during the embryonic period.A phenotype consisting of ptosis of the eyelids, downslant-
ing palpebral fissures, hypertelorism, developmental delay,
radioulnar synostosis, and periumbilical depression was
reported by Carnevale et al. in 1989 in two siblings from
a consanguineous Italian family (MIM 265050).1 In 1996,
Mingarelli et al. reported two sisters with similar ocular,
facial, and abdominal defects and additional skeletal
anomalies, but with normal intelligence, and suggested
that this phenotype be called oculo-skeletal-abdominal
(OSA) syndrome (also MIM 265050).2 Because of clinical
overlap with Michels syndrome3 (MIM 257920) and Mal-
puech syndrome4 (MIM 248340), it was subsequently sug-
gested that these four syndromes might belong to the
phenotypic spectrum of the same disorder, which could
be referred to as the 3MC (Malpuech-Michels-Mingarelli-
Carnevale) syndrome.5 Distinctive features have been
noted. The presence of anterior chamber eye anomalies
was suggested to be limited to Michels syndrome, and
growth and mental retardation, caudal appendage, and
cleft lip or palate were more frequently associated with
Malpuech syndrome.6 However, the combination of char-
acteristic facial and umbilical findings with anterior
chamber anomalies and caudal appendage in a further
family again suggested that these syndromes could be
causally related.7 The gene or genes responsible for these
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The AmericanWe ascertained two families from Turkey with pheno-
types very similar to those described by Carnevale et al.
(Figure 1A).1 The two patients in family 1 are sisters aged
15 years (individual 1-101; IV-1 in Figure 1B) and 10 years
(individual 1-102; IV-2 in Figure 1B). Their parents are first
cousins. Sisters 1-101 and 1-102 were born after uncompli-
cated pregnancies with apparently small birth weights (no
measurement was available). Initial gross and fine motor
skills, as well as speech development, were delayed. Height
and weight of 1-101 and 1-102 were 160 cm (between
the 25th and 50th centiles) and 51 kg (25th centile) and
148 cm (75th centile) and 46 kg (75th centile), respec-
tively. Both siblings had mild mental retardation with
full-scale IQ scores of 60–65. Pure tone audiograms indi-
cated that 1-101 had moderate (right) and profound (left)
mixed hearing loss and that 1-102 had mild mixed (right)
and profound sensorineural (left) hearing loss. High-reso-
lution CT scans of the temporal bone showed large vesti-
bules, large superior semicircular canals, and absent lateral
semicircular canals in both siblings. The facial phenotype
included highly arched eyebrows, hypertelorism, blephar-
optosis, broad and high nasal bridge with epicantus
inversus, downslanting palpebral fissures, and limited
upward gaze in both siblings and bifid nasal tip in 1-102
(Figure 1A and Table 1). Hypertelorism was considered
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Figure 1. Clinical Findings, Pedigrees, and MASP1 Mutations
(A) Phenotypic findings in affected individuals. Note hypertelorism, blepharoptosis, telecanthus, downslanting palpebral fissures,
arched eyebrows, and supraumbilical depression in all three patients. Bifid nasal tip and limitation of upward gaze are seen in individual
1-102 of family 1 and individual 2-101 of family 2. A coccygeal skin appendagewith a groove, characteristics ofMalpuech syndrome, and
high nasal bridge with posteriorly rotated ear are seen in individual 2-101 of family 2.
(B) Family 1 pedigree and longest autozygous run at chromosome 3q27 that cosegregates with the phenotype.
(C) Family 2 pedigree and haplotypes flanking the MASP1 gene.
(D) Confirmation of mutations in the MASP1 gene in families 1 and 2.deviation above the mean, and telecanthus was diagnosed
when the ratio of inner canthal distance to interpupillary
distance was bigger than 0.6.8 In 1-101, interpupillar,
outer, and inner canthal distances and palpebral fissure
lengths were 68 mm (>97th centile) and 10 cm (97th cen-
tile) and 37 mm (95th centile) and 31 mm (between the
50th and 75th centiles), respectively. In 1-102, interpupil-
lar, outer, and inner canthal distances and palpebral fissure
lengths measured 67 mm (>97th centile) and 10.2 cm
(>97th centile) and 40 mm (>95th centile) and 30 mm
(75th centile), respectively. Severe hypermetropy without
any anterior chamber anomalies, excessive skin over the
coccygeal area, and supraumbilical depression were pre-
sent in both siblings (Figure 1A). The older sister (1-101)680 The American Journal of Human Genetics 87, 679–686, Novembwas found to have right radioulnar synostosis and solitary
ectopic kidney. Echocardiography was normal in both
siblings. The parents and three siblings appeared to be
healthy, with no distinctive features.
The patient in family 2 (individual 2-101; IV-1 in
Figure 1C) is a female aged 9 years, the only affected child
of first-cousin parents. She was born at term with a birth
weight of 2800 g. Her initial developmental skills were
within the normal limits, with walking and starting to
talk at around 15 months of age. Her height, weight, and
head circumference at 9 years of age were 124.5 cm (10th
centile), 25 kg (25th centile), and 51 cm (25th centile),
respectively. Her interpupillar, outer, and inner canthal
distances and palpebral fissure lengths were 55 mm (75ther 12, 2010
Table 1. Phenotypic Findings of Carnevale, Michels, OSA, and Malpuech Syndromes and of Patients Reported in This Study
Phenotypic Findinga Michels3,5,25–28 Malpuech4,29–33 Carnevale1,6 OSA2
Family Reported
by Leal et al. as 3MC7
Family 1
Family 2,
2-1011-101 1-102
Short stature 6/10 10/13 0/4 0/2 0/2   
Mental retardation 4/9 11/13 1/4 0/2 0/2 þ þ þ
Craniofacial Findings
Arched eyebrows 10/10 13/13 4/4 2/2 2/2 þ þ þ
Telecanthus 9/10 12/14 4/4 2/2 0/2  þ þ
Hypertelorism 9/10 14/14 4/4 2/2 0/2 þ þ 
Blepharophimosis 9/10 2/13 0/4 0/2 1/2   
Blepharoptosis 10/10 7/13 4/4 2/2 2/2 þ þ þ
Downslanting
palpebral fissures
7/10 8/13 4/4 2/2 2/2 þ þ þ
Anterior chamber
anomalies
5/10 1/14 0/4 0/2 1/2   
Hearing loss 8/10 6/8 0/4 0/2 2/2 þ þ 
Cleft lip/cleft palate 7/10 14/14 1/4 0/2 0/2   
Abdominal Findings
Periumbilical depression 8/9 0/4 3/4 2/2 1/2 þ þ þ
Omphalocele/umbilical
hernia
2/9 4/6 0/4 0/2 2/2   
Skeletal Findings
Hip anomaly NA 0/5 3/4 0/2 0/2   
Deviated or short fingers 6/9 3/4 1/4 2/2 0/2 þ  þ
Limitation of elbow
movements
4/10 NA 3/4 1/2 1/2 þ  
Vertebral anomalies 2/5 2/6 0/2 2/2 1/2   
Genitourinary Anomalies
Genital 3/9 10/14 2/4 0/2 1/2   
Vesicorenal 5/7 8/13 0/2 0/2 0/2 þ  þ
Caudal appendage 0/5 5/9 NA NA 2/2 þ þ þ
NA denotes that information is not available.
a Numbers indicate patients with a specific finding among patients with published information on that finding.centile) and 10 cm (>97th centile) and 41mm (>95th cen-
tile) and 29 mm (between the 50th and 75th centiles),
respectively. The clinical phenotype included highly
arched eyebrows, telecanthus, high nasal bridge, blephar-
optosis, epicanthus inversus, limited upward gaze, down-
slanting palpebral fissures, ectropion of lateral third of
lower eyelids, synophyris, downturned corners of the
mouth, slightly bifid nasal tip, supraumbilical depression,
short and tapering fingers with fifth finger clinodactyly,
coccygeal skin appendage with a deep groove (Figure 1A),
and syndactyly between the second and third toes in the
right side. She was found to have mild mental retardation
(full-scale IQ was 54). Pure tone audiogram was normal.
Abdominal ultrasound showed fused cross ectopia of the
left kidney. Echocardiography showed small patent ductusThe Americanarteriosus at 9 years of age. The parents and the patient’s
sister had no phenotypic features of the syndrome.
Phenotypic features of these three patients were similar
to those reported in Carnevale, OSA, Malpuech, and
Michels syndromes (Table 1). Absence of anterior chamber
anomalies was not characteristic of Michels syndrome, and
normal height was not characteristic of Malpuech
syndrome, but both Michels and Malpeuch syndromes
are phenotypically heterogeneous. Overall, our patients
appeared to represent the combination of clinical findings
reported in Carnevale, OSA, Malpuech, and Michels
syndromes, similar to those reported by Leal et al. as
3MC syndrome (Table 1).7 A research protocol to evaluate
the families genetically was approved by the Ethics
Committee at the University of Ankara, Turkey and theJournal of Human Genetics 87, 679–686, November 12, 2010 681
Table 2. Rare Variants in the 1.813 Mb Homozygous Region on
Chromosome 3q27 Revealed by Whole Exome Sequencing in
Proband 1-101
SBP Indel Total
Number of variants with R10 reads and
variantR15% of total reads
4 0 4
Number of nonsense, missense, frameshift,
or splice variants
2 0 2
Nonsense, frameshift, splice 0 0 0
Missense at conserved site 1 0 1
SBP denotes single base pair substitutions. Indel denotes insertions or deletions
up to 20 bp in length.Institutional Review Boards at the University of Miami and
the University of Washington. All participants provided
informed consent or assent prior to enrollment.
Seven members of family 1 (individuals III-1, III-2, and
IV-1–5 in Figure 1B) and three members of family 2 (indi-
viduals III-2, IV-1, and IV-2) were enrolled (Figures 1B
and 1C). Chromosomal karyotype was normal in all three
affected individuals. DNA was extracted from peripheral
leukocytes, and homozygosity mapping was carried out
as previously described9 with Affymetrix 6.0 arrays.
In family 1, only one homozygous segment longer than
1.5 Mb was shared by both affected children but none
of their unaffected siblings (Figure 1B). This region was
1,812,702 bp between SNP markers rs3815620 and
rs2037184. In family 2, this 1.81 MB autozygous region
was embedded in a homozygous region of approximately
24 Mb that segregated with the phenotype (Figure 1C).
In order to identify the critical gene, genomic DNA of
the proband of family 1 was evaluated by whole exome
sequencing, as previously described.10 A total of 3.28 Gb
of sequence (215,986,000 pairs of reads) aligned to the
exome target. The proportion of the entire targeted exome
covered by >10 reads was 91.2%. DNA variants were
filtered against dbSNP131 and phase 3 of the 1000
Genomes project (March 2010 data release), then classified
by predicted function to include all missense, nonsense,
frameshift, or splice-site alleles. Because dbSNP includesTable 3. Amino Acid Substitutions in the MASP-3-Specific Exon Harbo
Locale (hg19) Substitution dbSNP131
chr3:186954107C>T p.V518I rs73068950
chr3:186953975C>A p.P562A rs72549155
chr3:186953932C>A p.R576M rs72549154
chr3:186953812A>G p.V616A rs2461280
chr3:186953749C>A p.R637L 
chr3:186953600C>T p.G687R 
chr3:186953491T>C p.E723G 
a Populations are defined on the HapMap website.
b Range is from 0.000 (most probably benign) to 0.999 (most probably damagin
682 The American Journal of Human Genetics 87, 679–686, Novembboth disease-associated and benign alleles, the analysis
was designed to include known SNPs identified as clini-
cally associated.
The 1.81 Mb autozygous region on chromosome 3q27
includes 20 genes, all of which were fully targeted by the
SureSelect All Exon kit. Whole exome sequencing yielded
>503 median coverage for this region. Four rare changes
were identified in the region (Table 2). One missense was
chr3:186,953,600C>T (hg19), supported by 78 sequence
reads, all of the mutant genotype, corresponding to
MASP1 c.2059G>A (NM_139125.3), leading to p.G687R
(NP_624302.1; Table 3). The other missense was chr3:187,
447,696T>G (hg19), corresponding to BCL6 c.497A>C
(NM_001706.4), leading to p.N166T (NP_001124317.1)
at a nonconserved site, with SIFT score 0.69 and PolyPhen2
classification benign (score 0.000). The other two rare
changes in the region were chr3:186,791,888G>C, at a
nonconserved intronic site in ST6GAL1 (NM_173216.2),
and chr3:186,410,219C>T, at a nonconserved intergenic
site.
MASP1 encodesmannan-binding lectin serine protease 1
(MIM 600521).11 MASP1 p.G687R occurs at a highly
conserved site in an exon specific to MASP1 isoform 2,
also known in the literature as MASP-3.12 MASP-3
p.G687R is predicted to be a damaging change, with SIFT
score 0.00 and PolyPhen2 classification ‘‘probably
damaging’’ (HumDiv score 0.983; HumVar score 0.902).
Data from the 980 individuals of the 1000 Genomes
Project Pilot 3 and data from dbSNP131 can be evaluated
to reveal the spectrum and predicted consequences of
mutations in control populations in this exon. Six amino
acid substitutions are reported (Table 3). All that appear
on dbSNP are rare, and those specific to 1000 Genomes
are also likely to be rare, given that they do not appear
on dbSNP. None are in conserved sites or are predicted to
be damaging to the protein. Therefore, in at least 1200
controls from multiple populations, this exon does not
sustain mutations with consequences predicted to be as
deleterious as p.G687R.
Sanger sequencing of the entire MASP1 gene in all rela-
tives of family 1 confirmed that both affected childrenring p.G687R in Family 1
1000 Genomes Pilot 3a PolyPhen2 HumVar scoreb
LWK, YRI 0.028
 0.038
LWK, CEU, YRI, CHB, CHD, TSI 0.081
 0.044
YRI 0.496
 0.902
JPT, CHD 0.079
g).
er 12, 2010
Table 4. Mutations in MASP1
Family Chr. Coordinate Variant Wild-Type Reads Variant Reads Effect Genotype of Affected Individuals
1 3 186,953,600 c.2059G>A 0 78 p.G687R Homozygous
2 3 186,970,978 c.870G>A Sanger sequence p.W290X Homozygouswere homozygous for p.G687R. Both parents and unaf-
fected sibling 1-105 were heterozygous, and the two other
healthy siblings (1-103 and 1-104) were homozygous for
wild-type alleles (Figure 1D). Primer sequences used for
sequencing are available in Table S1 available online.
Sanger sequencing of the complete MASP1 gene in
affected child 2-101 from family 2 revealed chr3:186,970,
978C>T, corresponding to MASP1 c.870G>A, leading to
a stop at p.W290X (Figure 1D; Table 4). This mutation
was homozygous in the affected child and heterozygous
in both her mother and an unaffected sister. Neither muta-
tion in MASP1 was detected in 192 healthy Turkish
controls or 1200 controls of various other ancestries.
The MASP-1 protein was first identified as a serine
protease activating the classical complement pathway by
binding to lectin.11 The MASP1 genetic locus is complex,Figure 2. Three Isoforms of the MASP1 Gene and Mutation Sites
(A)MASP1-encoded isoformsMASP-1, MASP-3, andMAp44, indicatin
serine protease domains differ between MASP-1 and MASP-3 and that
alteration is present in all three isoforms; p.G687R is present only in
(B) Conservation of residue G687 (arrow) in MASP-3 among vertebra
(C) Conservation of residue G687 (arrow) in the predicted substrate-b
obtained through the NCBI protein database.
The Americanencoding three isoforms that share amino acid residues
in their amino terminal regions but differ in their carboxy
terminals containing serine protease domains. The first
and second isoforms (MASP-1 and MASP-3) contain
different serine protease domains, and the third isoform
(also referred to as MAp44) lacks a serine protease domain
(Figure 2A). The nonsense mutation p.W290X in family 2
lies in coding exon 6, which is shared by all MASP-1 iso-
forms. The missense mutation p.G687R in family 1 is in
an exon unique to MASP-3. The mutant MASP-3 site
p.G687 is completely conserved from fish to humans
(Figure 2B) and lies at a predicted substrate binding site
that is highly conserved across a wide variety of serine
protease domains (Figure 2C). MASP-3 is 728 amino acids
in length.12 The locale of the missense mutation suggests
that the phenotype associated with the two MASP1g that the N-terminal amino acids are identical but the trypsin-like
MAp44 does not contain a serine protease domain. The p.W290X
MASP-3.
tes.
inding site of various trypsin-like serine proteases. Alignment was
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Figure 3. Ribbon Representation of 3D Atomic
Models of the Serine Protease Domain of Human
MASP-3
(A and B) Wild-type (A) and mutant (B) G687R.
The serine protease canonical fold is comprised
of two six-stranded b-barrels packed against
each other (brown). Side chains of the catalytic
triad H497/D553/S664 within the enzyme active
site are shown in blue; side chains of D658 and
G687/R687 are in green. Amino acid residues
451–728 are the boundaries of the serine protease
domain of human MASP-3.mutations may be due specifically to impairment of the
MASP-3 isoform.
To further understand the physiological significance of
the p.G687R alteration, we generated 3D atomic models
of the serine protease domain of human MASP-3 on
the basis of amino acid sequence homology with the
known crystal structure of human MASP-1 (PDB# 3GOV;
Figure 3).13 Homology modeling was carried out with
MODELER software.14,15 The serine protease domains of
MASP-1 andMASP-3 share 35% amino acid sequence iden-
tity in the core catalytic regions. Thus, the atomic models
of the wild-type and the G687R-variant serine protease
domains of MASP-3 would be expected to adopt 3D folds
fairly similar to the template structure. For each case, 100
atomic models were calculated, and the structures with
the lowest energies, as judged by the MODELER Objective
Function, were selected for further analysis. The atomic
models were rendered with RIBBONS.16 The modeled
structures display the canonical serine protease fold
comprised of two six-stranded b-barrels tightly packed
against each other. The enzyme active site contains the
catalytic triad H497/D553/S664, characteristic of all serine
proteases and located at the junction of the two b-barrels
within a deep cleft. Residue G687 is located within the
active site close to the junction of the two b-barrels and
in close proximity to D658, an acidic residue key to proper
organization of the active site and to stabilization of
incoming protein substrates.13,17 Given the close prox-
imity of D658 to G687, the p.G687R variant would likely
result in the formation of an intermolecular salt bridge684 The American Journal of Human Genetics 87, 679–686, November 12, 2010through ion pairing of the carboxylic side
chain group of D658 and the guanidino
side chain moiety of p.G687R. A D658-
G687R salt bridge could lead to disorganiza-
tion and distortion of the active site, with
misalignment and disorientation of the
catalytic triad H497/D553/S664. In conse-
quence, both the protein recognition
function and catalytic function of the
serine protease domain of MASP-3 could
be compromised. Similar internal salt
bridges within the active sites of MASP-1
and complement factor D are known to
render them catalytically inactive.12,18–20Although it remains to be tested experimentally, the
atomic model suggests that the p.G687R variant in
MASP-3 may be catalytically lethal.
MASP-1 and MASP-3 share a domain structure with C1r
and C1s, two serine proteases of the classical complement
pathway. C1s selectively cleaves insulin-like growth factor
binding protein (IGFBP-5), which is thought to regulate
physiologic processes in kidney, bone, and elsewhere.
IGFBP-5 also binds to IGFs, such as IGF-I, in extracellular
space and, in this way, regulates the interaction of IGFs
with their receptors on cell surfaces.21 Although binding
of IGFBPs to IGFs generally leads to downmodulation
of IGF signaling, it can also stabilize IGF, resulting in
a net increase in signaling.22 It has been suggested that
MASP-3 processes IGFBP-5.23 Interestingly, IGFBP-5 is ex-
pressed in the craniofacial region duringmouse embryonic
development, and IGFBP-5 mRNA was found in mouse
epithelium at early stages, corresponding to completion
of neural crest migration. Also, IGFBP5-expressing cells
were present around developing cartilage and bone during
differentiation of craniofacial mesenchyme into skeletal
tissue. Overexpression of IGFBP-5 in mice causes decreased
ossification or deletion of head bones.22 Finally, IGFBP-5 is
also thought to promote muscle cell differentiation by
switching on the IGF-II autoregulation loop.24 In total,
these results suggest that processing of IGFBP-5 by
MASP-3 may play a critical role in IGF availability during
craniofacial and muscle development.
Involvement of MASP-3 in the IGF signaling pathway
could explain the dysmorphic facial features, skeletal
abnormalities, and defects in muscular development that
are present in our patients. It will be informative to learn
the consequences to embryonic development of different
mutations in MASP1. Sequencing MASP1 in more patients
with these phenotypes will also illuminate both locus and
allelic heterogeneity—in particular, whether Michels,
Malpuech, OSA, and Carnevale syndromes are different
genetic entities, represent different phenotypic manifesta-
tions of a spectrum of mutations in the same gene, or both.Supplemental Data
Supplemental Data include one table and can be found with this
article online at http://www.cell.com/AJHG/.Acknowledgments
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